FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Eli Lilly to outsource half of research by 2010

Tools

While other big pharma companies have been making headlines with big layoffs and global restructuring plans, Eli Lilly has been steadily chipping away at its own strategy--quietly outsourcing jobs and services for research and manufacturing around the world as it gradually lowers its head count. About 40 percent of its IT work has already been outsourced with outside partners expected to handle half of its research work by 2010.

- read the report on Lilly's plans from the Indianapolis Star

Related Articles:
Lilly developing biotech drugs the old-fashioned way. Report
Lilly declares a truce in diabetes rep war. Report
Top Lilly exec plays secret sales agent. Report
Lilly predicts double-digit earnings growth. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Diabetes   biotech drugs   pharmaceutical companies   layoffs   Eli Lilly   restructuring